-1.png)
Via practica S3/2010
Risk perceptions in the antiaggregation preventive therapy
therapy in the reduction of acute vascular events. On the other hand, there is considerable risk associated with this therapy. Bleeding and other adverse drug reactions often limit the usage of the basic antiplatelet drug, that is aspirin. Clopidogrel has proved better tolerance as well as effectivity in this setting. The inadequate drug risk perception may negatively influence the prescriptive decisions of doctors and patients´ adherence to the treatment. The authors of the review article aimed to show the limits of the chosen drugs.
Keywords: risk perceptions, safety of drugs, adherence to the treatment, aspirin
